CEREBEL (EGF111438): A Phase III, Randomized, Open-Label...

Journal of Clinical Oncology 2015 / 05 Vol. 33; Iss. 14

CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

Pivot, X., Manikhas, A., Zurawski, B., Chmielowska, E., Karaszewska, B., Allerton, R., Chan, S., Fabi, A., Bidoli, P., Gori, S., Ciruelos, E., Dank, M., Hornyak, L., Margolin, S., Nusch, A., Parikh, R
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2014.57.1794
Date:
May, 2015
File:
PDF, 256 KB
english, 2015
Conversion to is in progress
Conversion to is failed